1 / 38

Immunopharmacology 免疫药理学

Immunopharmacology 免疫药理学. 2010.12. Types of Drugs. Immunosuppressants ( important! ) Immunostimulants Immunomodulators Induction of tolerance (tolerogens) Cytokines Hematopoetic growth factors Antibodies targeting key cell receptors/ligands. Simplified schematic of an immune response.

kamea
Download Presentation

Immunopharmacology 免疫药理学

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Immunopharmacology免疫药理学 2010.12

  2. Types of Drugs • Immunosuppressants (important!) • Immunostimulants • Immunomodulators • Induction of tolerance (tolerogens) • Cytokines • Hematopoetic growth factors • Antibodies targeting key cell receptors/ligands

  3. Simplified schematic of an immune response proliferation & differentiation CD8+ T cells CD8+ cytolytic T cells Class I IFNg, IL-2 APC proliferation & differentiation CD4+ immune cells (delayed hypersensitivity) Class II CD4+ T cells Cytokines Costim. Mol. IL-4,-5,-6 B cells Protein antigens Plasma cells proliferation & differentiation antibody production MHC class II/peptides APCs

  4. Major steps in immune responses CD8 T cell Antigen IL-2 cytotoxic T cells 1 4 3 2 primed CD4 T helper cell IL-2 IL-1 antigen presenting cell (macrophage, dendritic cell) CD4 T helper cell plasma cells 4 IL-2 B cell

  5. Sites of action of immunosuppressive drugs CD8 T cell 4 Antigen IL-2 X cytotoxic T cells 1 E X C A X 3 2 primed CD4 T helper cell X X D D IL-2 IL-1 B antigen presenting cell CD4 T helper cell 4 plasma cells X cytokines

  6. Immune response The cell-mediated arm of the immune response involves the ingestion and digestion of antigen by antigen-presenting cells such as macrophages. Activated TH cells secrete IL-2, which causes proliferation and activation of cytotoxic T lymphocytes, and TH1 and TH2 cell subsets. TH1 cells also produce IFN-γ and TNF-β, which can directly activate macrophages and NK cells. The humoral response is triggered when B lymphocytes bind antigen via their surface immunoglobulin. They are then induced by TH2-derived IL-4 and IL-5 to proliferate and differentiate into memory cells and antibody-secreting plasma cells. Regulatory cytokines such as IFN- γ and IL-10 down-regulate TH2 and TH1 responses, respectively.

  7. Purpose of immunosuppressive drugs • Prevention of organ transplant rejection • Treatment of autoimmune diseases • Multiple Sclerosis(多发性硬化) • Lupus (红斑狼疮) • Rheumatoid Arthritis (类风湿性关节炎) • Crohn’s Disease(节段性回肠炎) • Type I Diabetes (1型糖尿病) • …

  8. Glucocorticoids • reducing the size and lymphoid content of the lymph nodes and spleen • interfering with the cell cycle of activated lymphoid cells • lowering the effective concentration of specific antibodies

  9. Biology of glucocorticoids Newton, Thorax 2000; 55:603-613

  10. Mechanisms of Glucocorticoid Action • Inhibit the production of • proinflammatory cytokines • Promote the production of inflammatory cytokines • Induce apoptosis in • inflammatory cells • 4. Interfere with cytokine signals Newton, Thorax 2000;55:603-613

  11. Glucocorticoid-sensitive sites of the immune response proliferation & differentiation X MHC Class I/peptides APCs CD8 T-cell CD8 cytolytic T-cells X GC GC IL-2 MHC Class II/peptides APCs proliferation X CD4 immune cell (delayed hypersensitivity) CD4 T-cell (helper T-cells) X IL-1 IL-1, -4,-5,-6 B-cell Protein antigen Plasma cell proliferation & differentiation antibody production

  12. Clinical uses • Autoimmune diseases Idiopathic thrombocytopenic purpura (特发性血小板减少性紫癜) • Autoimmune hemolytic anemia (自主免疫溶血性贫血) • Acute glomerulonephritis(肾小球肾炎) • Acquired factor XIII antibodies and bleeding syndrome • Organ transplantation  • Prevention of cell proliferation induced by coronary stents (支架) • …

  13. Cyclosporin (环孢素) isolated from the fungus Tolypocladium inflatum (多孢木霉菌) isolated from a soil sample obtained by Sandoz scientists at Hardangervidda, Norway in 1969

  14. Immunophilin(免疫亲和素) ligands • Cyclosporine(环孢素):peptide antibiotic • Cyclosporine + cyclophilin → complex → inhibiting cytoplasmic phosphatase, calcineurin(钙调磷酸酶,necessary for the activation of a T-cell-specific transcription factor)

  15. Targets of Immunosuppressants cyclophilin FK Binding protein sirolimus Cyclosporine tacrolimus mTor Calcineurin NFAT Translocation Cytokine Signaling Genes lead to T cell Activation; IL-2转录↓

  16. Mechanism of Action of Helper T-cell blockers X X From Hardman and Limbird, The Pharmacological Basis of Therapeutics

  17. Clinical uses • organ transplantation: • Body parts: Facial, Limbs, • Organs: Heart, kidney, liver, small intestine, lung, … • Tissues: Islets, hair follicles, bone, bone marrow, cornea, … • Cells: Stem cells, lymphocytes

  18. Immunological Rejection Major Histocompatibility Complex (基因群) MHC编码细胞表面组织相容性抗原,无器官特异性,不同个体间抗原特异性不同,但同卵双生及纯系动物不同个体之间,其抗原特异性完全一致。 Rejections: Antibody mediated T cells mediated Hyperacute rejection e.g., Blood type mismatch Acute Graft Rejection Direct recognition of allogeinic MHC; rejection about 10 days Chronic rejection Take many months to years. Due to failure of immunosuppressants

  19. Clinical uses • graft-versus-host disease(移植物抗宿主疾病) after hematopoietic stem cell transplantation • selected autoimmune disorders

  20. Tacrolimus(他克莫司) • macrolide antibiotic 23-membered macrolide lactone discovered in 1984 from the fermentation broth of a Japanese soil sample that contained the bacteria Streptomyces tsukubaensis.

  21. Tacrolimus • binding to the immunophilin FK-binding protein→inhibiting the cytoplasmic phosphatase, calcineurin • 10-100 times more potent than cyclosporine • used in organ and stem cell transplantation

  22. Sirolimus (西罗莫司) • Structure • macrolide similiar to tacrolimus • Mechanism • binds to immunophilin protein that binds to a key regulatory kinase required for T cell activation • (new unique mechanism to inhibit T lymphocyte activation by IL-2) • different site of action than cyclosporine and tacrolimus

  23. Targets of Immunosuppressants immunophilin FK Binding protein sirolimus Cyclosporine tacrolimus mTOR Calcineurin NFAT Translocation Cytokine Signaling Genes lead to T cell Activation; IL-2转录↓

  24. Consequences of mTOR action • Lymphocyte cell proliferation & differentiation • T cells • B cells • Antibody production • Mesenchymal cell proliferation • Vascular smooth muscle cells • Endothelial cells • Fibroblasts

  25. Sirolimus • Inhibits mammalian target of rapamycin (mTOR) • mTOR is a protein kinase that plays pivotal role in IL-2 receptor responses • IL-2 binds to its receptor on T cells and leads to mTOR activation • mTOR initiates cascade of events (including cyclin dependent kinases) that promote T lymphocyte proliferation and differentiation • Inhibition of mTOR blocks IL-2 dependent cell-cycle progression at G1→S phase transition

  26. Mycophenolate mofetil(霉酚酸酯) • Penicillium glaucum(灰绿青霉菌) • inhibiting T- and B-lymphocyte responses Very often used now • alternative to cyclosporine, solid organ transplant patients • lupus nephritis, rheumatoid arthritis, and some dermatologic disorders

  27. Cytotoxic agents • Azathioprine(硫唑嘌呤) • prodrug of mercaptopurine,functions as an antimetabolite

  28. Cytotoxic agents • Cyclophosphamide(环磷酰胺) • autoimmune disorders (including systemic lupus erythematosus系统性红斑狼疮) • acquired factor XIII antibodies and bleeding syndrome • autoimmune hemolytic anemia • antibody-induced pure red cell aplasia(发育不全) • Wegener‘s granulomatosis(肉芽肿)

  29. Drug Glucortiocoids Cyclosporine and Tacrolimus Sirolimus Mycophenolate Mofetil Target GRE of DNA (regulate gene transcription, inhibit transcription) Calcineurin (inhibit the phosphatase required for IL-2 transcription) Protein kinase involved in cell-cycle progression (inhibits mTOR and inhbits IL-2 signaling) Inosine monophosphate dehydrogenase (inhibits de novo guanine nucleotide synthesis) Immunosuppressants Inhibiting T Cell Activation

  30. Monoclonal antibody • 1975, hybridoma technology by Milstein and Kohler • antibody-forming cells fused to immortal plasmacytoma cells[举例:脾细胞分泌抗体+骨髓瘤细胞(永生性)] • Pure and mass antibody possible • Antilymphocyte & Antithymocyte Antibodies • Muromonab-CD3 against T-cell surface proteins(莫罗单抗) • …

  31. Inhibitors of immune response A- Immune Globulin(antigen recognition) B- Corticosteroids(IL-1 production, cell proliferation) C- Cyclosporine, Tacrolimus, (1L-2 gene expr.), Sirolimus (IL-2 signal transduction) D- Rapamycin, Mycophenolate(T cell prolif.), Azathioprine, Cyclophosphamide (all cell prolif.) E- OKT3 (Muromonab-CD3) (monoclonal antibody to CD3 on T cell)

  32. Immunostimulants • Thymic Hormones • Improve primary immune deficiency in children • Synthetic Stimulants • Levamisole stimulates phagocytosis and T cell production of cytokines • Adjuvants of bacterial origin • Bacille de Calmette Guerin (BCG, 卡介菌) is viable strain of Mycobacterium bovis that enhances macrophage activity • BCG used for bladder cancer and melanomas

  33. hepatitis B vaccine • a small glycoprotein, hepatitis B surface antigen (HBsAg) • child's immune system recognizes HBsAg as foreign • produces antibodies • when infected with hepatitis B virus • the antibodies recognize the protein and stimulate the immune system to produce large quantities of specific antibodies that attach to and destroy the virus and prevent the disease.

  34. vaccination • a child receives vaccination, most often before leaving the hospital after birth. • the second and third HBV immunizations are administered by the age of 18 months, in conjunction with other routine childhood vaccinations.

More Related